STAT3 and central nervous system cancer: Summing up the above literature with the clinical data from The Cancer Genome Atlas (TCGA) database strongly suggests that CDK6/mTOR/STAT3 overexpression is correlated with a high glioma grade, lower survival, and poor prognosis in glioblastoma patients [18,23].